Uf

Could you clarify what you mean by “Uf”?

Sodium profiling and uf profiling in detail indicates contradiction how to set graph detail

Reading File
Finding Sources
Searching PubMed

hemodialysis AND sodium profiling

Searching the Web

hemodialysis machine sodium and ultrafiltration profiling programming clinical guideline

Reading File
In hemodialysis, sodium profiling and UF profiling are not inherently contradictory. They must be coordinated so that the highest dialysate sodium support coincides with the highest UF rate, usually early in treatment.

What each profile does

ProfileWhat changes during dialysisMain intended effectMain risk
Sodium profilingDialysate sodium concentrationHigher sodium early supports plasma osmolality, thirst-free vascular refill, and BP stabilityNet sodium gain causes thirst, higher interdialytic weight gain, and hypertension
UF profilingUF rate, not total prescribed UF volumeRedistributes fluid removal across the sessionExcess early UF can still cause hypotension if refill is poor
A common sodium profile begins around 145 mmol/L and gradually reaches 135 mmol/L by the end. A front-loaded UF profile may remove roughly two-thirds of the planned fluid during the first half, although benefit remains debated. Comprehensive Clinical Nephrology, 7th ed., p. 764 (text lines 1964-1973).

Why the graph may look “opposite”

A typical coordinated setup is:
  • Sodium: high at start, then declines.
  • UF rate: high at start, then declines.
  • Therefore, both curves decline with time. They are parallel, not opposing.
The logic:
  1. In the first part of dialysis, UF is higher.
  2. Higher dialysate sodium helps maintain extracellular osmolality and vascular refill during that higher fluid-removal phase.
  3. Sodium must then taper down to reduce the chance of ending the session with a positive sodium balance.
  4. UF rate also falls later, when plasma refill may be less able to compensate.

Example graph

Use time on the x-axis and create two y-axes:
  • Left y-axis: dialysate Na, mmol/L
  • Right y-axis: UF rate, mL/h
  • Do not put cumulative UF volume and UF rate on the same axis, because they are different quantities.
Dialysis time        0 h        1 h        2 h        3 h        4 h
----------------------------------------------------------------------
Dialysate Na         145        142        140        137        135 mmol/L
UF rate              1100       1000       750        550        400 mL/h
Illustrative shape:
Dialysate Na
145 |●
142 |  ●
140 |    ●
137 |      ●
135 |        ●
    +---------------------------------
      0 h     1 h     2 h     3 h   4 h

UF rate
1100|●
1000|  ●
 750|    ●
 550|      ●
 400|        ●
    +---------------------------------
      0 h     1 h     2 h     3 h   4 h

Example in percentages

If the prescription is 3.0 L UF over 4 hours:
SegmentTimeUF volumeUF rateDialysate sodium
10-1 h0.90 L900 mL/h145 mmol/L
21-2 h0.80 L800 mL/h142 mmol/L
32-3 h0.70 L700 mL/h138-140 mmol/L
43-4 h0.60 L600 mL/h135 mmol/L
Total4 h3.00 Laverage 750 mL/hsodium ends low
This is only a graphing example, not a patient prescription.

The important “contradiction”

The apparent contradiction is in the goals:
  • You use higher sodium early to reduce intradialytic hypotension.
  • But excess sodium can lead to thirst, greater fluid intake, interdialytic weight gain, and hypertension.
  • High UF early may improve early fluid removal but can worsen instability when the patient has poor plasma refill, cardiac dysfunction, autonomic dysfunction, or an incorrect target weight.
Thus, use the lowest sodium exposure and least aggressive UF profile that achieves stable dialysis, rather than routinely using sodium profiling.
Textbook guidance specifically warns that sodium profiling can produce sodium loading, thirst, weight gain, and higher BP, so its need should be re-evaluated if these occur. Comprehensive Clinical Nephrology, 7th ed., p. 764. A 2024 Cochrane review also indicates that the evidence on lower dialysate sodium and longer-term patient outcomes remains limited and uncertain.

Practical setup rule

For machine programming, have the nephrologist or dialysis unit protocol define:
  1. Total UF goal: based on pre-HD weight, target weight, and intradialytic intake.
  2. Treatment time: increase time rather than forcing a high UF rate when possible.
  3. UF profile: usually descending, if profiling is indicated.
  4. Sodium profile: starts high and returns to the unit baseline by the end, avoiding net sodium loading.
  5. Monitoring: BP, symptoms, post-dialysis weight, thirst, interdialytic weight gain, predialysis BP, and serum sodium.
Avoid creating a high sodium profile for routine use in patients with uncontrolled hypertension, large interdialytic weight gain, marked thirst, or recurrent volume overload unless the dialysis clinician has a specific rationale.

Sodium profiling and uf profiling in dialysis detail indicates contradiction how to set on machine at what number what graph comes graph detail In detail

Reading File
Finding Sources
Finding Sources
Searching PubMed

hemodialysis AND sodium AND ultrafiltration profiling

Searching the Web

hemodialysis sodium profiling ultrafiltration profiling settings machine manual sodium 145 135 UF profile

Reading Web Page

https://freseniusmedicalcare.com/content/dam/fmcna/live/supp…

Reading Article

PMID: 38605298

Finding Sources

First: the apparent contradiction

Sodium profiling changes dialysate sodium concentration.
UF profiling changes the rate of fluid removal.
They are coordinated for patients with recurrent intradialytic hypotension, but the combination is not routine because sodium profiling can cause sodium loading, thirst, larger interdialytic weight gain, and hypertension.
There are two different graph concepts:
  1. Descending UF + descending sodium
    High UF early, then lower UF later. Sodium is also high early, then tapers down.
    This is the traditional combination.
  2. Ascending-descending UF + descending sodium
    Low UF at the beginning, highest UF in the middle, low UF at the end. Sodium falls continuously from high to low.
    This looks “contradictory” because the UF peak is in the middle while sodium is already falling. It is an experimental or selected-patient approach, not a universal rule.
A small 2024 crossover trial reported fewer symptomatic hypotension episodes with an ascending-descending UF profile plus a descending sodium profile, but it included only 20 patients and does not establish a standard machine prescription. See the trial abstract.

1. Sodium profile graph

Typical descending sodium profile

Dialysate sodium, mmol/L

150 | ●
148 |   ●
146 |     ●
144 |       ●
142 |         ●
140 |           ●
138 |             ●
136 |               ●
    +-----------------------------------------
      Start     1 h      2 h      3 h     End

Common numeric range reported in references

Dialysis phaseUsual sodium-profile concept
Start145-150 mmol/L
Middle140-145 mmol/L
End135-140 mmol/L
Unit baseline, if no profileoften 138-140 mmol/L
Textbooks describe sodium modeling as reducing dialysate sodium gradually from about 145-155 mmol/L to 135-140 mmol/L near the end of dialysis. The reason is to provide early osmotic support while avoiding a positive sodium balance at treatment completion.
Important: A high start such as 150-155 mmol/L is not automatically appropriate. It can worsen thirst, interdialytic weight gain, and hypertension. It should be avoided or reconsidered in patients who already have those problems.

2. UF profile graph

First calculate the average UF rate:
[ \text{Average UF rate (mL/h)} = \frac{\text{total UF goal in mL}}{\text{UF time in hours}} ]
Example only:
  • UF goal = 3,000 mL
  • UF time = 4 hours
[ 3000 \div 4 = 750\text{ mL/h average UF rate} ]
The UF rate is also assessed in relation to body weight:
[ \text{Weight-adjusted UFR} = \frac{\text{UF mL/h}}{\text{post-dialysis target weight in kg}} ]
The proper UF goal and maximum acceptable rate must be prescribed by the nephrologist. If the required rate is not tolerated, the safer solution is usually less interdialytic gain, longer treatment, or an additional treatment, not simply an aggressive profile. The National Kidney Foundation overview similarly notes that excessive fluid removal can cause hypotension and cramps and may require longer or extra dialysis.

3. Pattern A: descending UF with descending sodium

This is the easiest graph to understand and the most commonly discussed pairing.

Graph

Time                   Start        1 h        2 h        3 h       End
---------------------------------------------------------------------------
Dialysate Na            145        142        140        137        135 mmol/L
UF rate                1050        900        750        600        450 mL/h
Na concentration
145 | ●
142 |   ●
140 |     ●
137 |       ●
135 |         ●
    +----------------------------------------------
      Start     1 h      2 h       3 h      End

UF rate
1050| ●
 900|   ●
 750|     ●
 600|       ●
 450|         ●
    +----------------------------------------------
      Start     1 h      2 h       3 h      End

Why this pairing makes physiological sense

Early dialysisLate dialysis
Fluid excess is usually greaterPlasma refill may be lower
UF rate is higherUF rate is reduced
Dialysate sodium is higherSodium is brought down to baseline
Aim: maintain blood pressure and vascular refillAim: finish without sodium loading
So the curves run in the same downward direction. There is no contradiction.

Example using a 3 L UF goal over 4 h

For a 3 L UF goal over 4 hours, average UFR is 750 mL/h. A linear descending example is:
TimeUF rateSodium
Start1,050 mL/h145 mmol/L
1 h900 mL/h142 mmol/L
2 h750 mL/h140 mmol/L
3 h600 mL/h137 mmol/L
End450 mL/h135 mmol/L
This profile averages 750 mL/h over the full treatment. It is a mathematical illustration only, not a prescription for a particular patient.
A Fresenius 2008T linear descending UF profile described in a trial protocol began at 140% of the average prescribed UFR, reached 100% at mid-treatment, and ended at 60%. In the example above: 1,050 mL/h at start, 750 mL/h at midpoint, and 450 mL/h at end. The study protocol explains this profile structure.

4. Pattern B: ascending-descending UF with descending sodium

This is the profile that often creates confusion.

UF graph

UF rate, mL/h

1000|                 ●
 800|           ●           ●
 600|     ●                       ●
 400| ●                                 ●
    +-----------------------------------------
      Start     1 h      2 h      3 h     End

Sodium graph

Dialysate Na, mmol/L

150 | ●
147 |   ●
144 |     ●
141 |       ●
138 |         ●
    +-----------------------------------------
      Start     1 h      2 h      3 h     End

Example distribution from the 2024 study

The reported intervention had three UF phases:
UF phaseApproximate share of total UFConcept
Early ascending phase25.5%lower UF
Middle phase51.2%highest UF
Late descending phase23.6%lower UF
Sodium150 to 138 mmol/Llinear downward sodium profile
For a 3.0 L total UF goal, that would be approximately:
PhaseApproximate UF volume
Early765 mL
Middle1,536 mL
Late708 mL
Total3,009 mL due to rounding
This is not contradictory because the intended mechanism differs:
  • Early low UF: allows initial equilibration and vascular refill.
  • Middle high UF: removes the main fluid volume while the patient is more stable.
  • Late low UF: reduces late-session hypotension.
  • Sodium declining throughout: limits final sodium loading.
But this approach should be used only if the dialysis clinician has selected it for a patient with recurrent intradialytic hypotension and has reviewed BP, interdialytic weight gain, target weight, cardiac status, and sodium balance.

5. How to enter it on the machine

The exact menu differs between Fresenius, Baxter, Nipro, B. Braun, and other machines. Do not copy another manufacturer’s settings or profile numbers.

Generic sequence

  1. Confirm the nephrologist’s prescription:
    • dry weight or target weight
    • total UF goal
    • prescribed treatment time
    • dialysate sodium baseline
    • whether sodium profiling is specifically ordered
    • prescribed UF profile type
  2. Enter:
    • UF goal in mL
    • UF time in hours/minutes
    • the prescribed UF profile
    • the prescribed sodium-profile start, end, and shape if that feature is ordered
  3. Check the machine-displayed:
    • maximum UF rate
    • total planned UF
    • profile graph
    • dialysate sodium or conductivity graph
    • machine safety limits and alarms
  4. During dialysis, monitor:
    • BP and symptoms
    • cramps, nausea, yawning, dizziness
    • blood-volume trend if available
    • net sodium balance or conductivity data if the machine provides it
    • post-dialysis BP and weight
    • thirst and interdialytic weight gain over subsequent sessions

Fresenius 2008T example only

On the Fresenius 2008T, the clinician selects the UF Goal and UF Time, opens UF Profile, chooses the prescribed profile, and confirms it. The machine calculates and displays the profile’s maximum UF rate. It can divide the remaining treatment into 12 equal time segments. If the calculated maximum rate is too high, the manual directs the operator to increase UF time, reduce UF goal, or choose a different profile, rather than proceed with an excessive rate. See the 2008T operator manual.
Do not assume “Profile 1” or “Profile 2” means the same thing on every machine. Manufacturer profile numbering is not universal.

6. When sodium profiling should usually be avoided or re-evaluated

Reconsider sodium profiling when the patient has:
  • uncontrolled predialysis or interdialytic hypertension
  • marked thirst after dialysis
  • rising interdialytic weight gain
  • recurrent fluid overload
  • evidence of sodium loading
  • no improvement in intradialytic hypotension despite profiling
A recent evidence warning: systematic reviews of lower dialysate sodium have found uncertainty about several long-term outcomes, so sodium prescriptions should be individualized rather than using high sodium or sodium profiling routinely. See the 2024 Cochrane review.

Simple rule to remember

High UF rate  ->  higher sodium support may be used early
Low UF rate   ->  sodium should taper toward baseline
End of HD     ->  avoid finishing with high dialysate sodium
Best practical graph for a conventional descending profile:
Sodium:  145  -> 142 -> 140 -> 137 -> 135 mmol/L
UF rate: 1050 -> 900 -> 750 -> 600 -> 450 mL/h
Those numbers are a teaching example based on 3 L over 4 hours, not a universal setting. The actual numbers must be set from the individual prescription, body weight, blood pressure tolerance, sodium balance, and machine-specific protocol.

Indications of dialysis for nephrologist in detail

Reading File
Finding Sources
Finding Sources
Searching PubMed

acute kidney injury AND renal replacement therapy

Searching the Web

KDIGO 2024 dialysis initiation indications kidney failure practice guideline symptoms refractory hyperkalemia acidosis volume overload

Reading File
Reading File
Reading File
Reading Web Page

https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-…

Indications for Dialysis: Nephrology Approach

Dialysis is a form of kidney replacement therapy used when the kidneys cannot adequately control:
  1. Potassium and other electrolytes
  2. Acid-base balance
  3. Fluid volume
  4. Uremic toxin accumulation
  5. Specific dialyzable poisons
The decision is clinical, not based on serum creatinine, urea, or eGFR alone.

1. Emergency dialysis in acute kidney injury: AEIOU

The standard bedside mnemonic is AEIOU.
LetterIndicationWhat makes it a dialysis indication?
AAcidosisSevere metabolic acidosis that is refractory to appropriate medical treatment
EElectrolyte abnormalityEspecially severe or refractory hyperkalemia, particularly with ECG changes
IIntoxicationA toxin that is dialyzable and causing or likely to cause severe toxicity
OOverloadPulmonary edema or uncontrolled volume overload despite diuretics and supportive care
UUremiaSymptomatic uremia, such as pericarditis, encephalopathy, bleeding, severe nausea/vomiting, or seizures
KDIGO advises emergency RRT when there are life-threatening fluid, electrolyte, or acid-base disturbances and emphasizes evaluating the clinical context and trends rather than using one BUN or creatinine cutoff. See the KDIGO AKI guideline.

A. Acidosis

Indication

Start dialysis when there is severe metabolic acidosis that is persistent or refractory despite treating the cause and giving appropriate medical therapy.

Typical concerning features

  • Severe acidemia, often around pH ≤7.1, though there is no universal absolute threshold
  • Persistently low bicarbonate with worsening acidemia
  • Hemodynamic instability, arrhythmia, reduced myocardial contractility, or respiratory fatigue due to acidosis
  • Acidosis with AKI when bicarbonate therapy is ineffective, unsafe, or causes volume overload
  • Severe lactic acidosis when renal failure prevents correction and the underlying illness remains active
  • Toxic alcohol ingestion with major acidosis

Clinical principle

Do not dialyze merely because bicarbonate is low. Dialysis is indicated when the acidosis is severe, clinically harmful, and cannot be corrected safely by treating the cause and medical therapy.
The Washington Manual identifies refractory severe acidosis as an urgent dialysis indication and describes pH <7.2 as severe acidosis requiring close management. The Washington Manual of Medical Therapeutics, p. 483.

E. Electrolyte disorders

1. Hyperkalemia: most important electrolyte indication

Dialysis is urgent if hyperkalemia is:

  • Severe and refractory to medical therapy
  • Associated with ECG abnormalities
  • Recurrent after temporary intracellular shifting therapy
  • Occurring with severe AKI, anuria, advanced CKD, or ongoing tissue breakdown
  • Associated with arrhythmia, muscle weakness, or cardiac arrest

ECG features that increase urgency

Peaked T waves
Shortened QT interval
PR prolongation
Loss of P waves
QRS widening
Sine-wave pattern
Ventricular tachyarrhythmia or cardiac arrest

Important distinction

Medical treatment can temporarily stabilize or shift potassium:
  • IV calcium stabilizes the cardiac membrane
  • Insulin with glucose shifts potassium intracellularly
  • Nebulized beta-agonist shifts potassium intracellularly
  • Bicarbonate may help in selected acidemic patients
But these do not reliably remove total body potassium. Hemodialysis removes potassium from the body. Therefore, recurrent or refractory hyperkalemia is a dialysis indication.
The Washington Manual of Medical Therapeutics, p. 483, states that severe hyperkalemia refractory to medical management is an urgent indication for dialysis.

2. Other electrolyte indications

These are less common but may require dialysis if severe and refractory:
  • Severe hypermagnesemia with cardiac, respiratory, or neurologic toxicity, especially in renal failure
  • Severe hyperphosphatemia, especially in tumor lysis syndrome
  • Severe hypercalcemia when standard therapy fails or cannot be used due to renal/cardiac failure
  • Severe hyponatremia or hypernatremia in selected renal-failure cases when controlled correction is otherwise impossible
Caution: Severe dysnatremia requires carefully prescribed dialysis or CRRT to avoid overly rapid sodium correction.

I. Intoxications and poisonings

Dialysis is useful only for selected substances. A poison is more likely to be dialyzable when it has:
  • Low molecular weight
  • Low protein binding
  • Low volume of distribution
  • Water solubility
  • Severe toxicity that is not controlled with antidotes/supportive care

Commonly tested dialyzable toxins: “MUDPILES” concept

ToxinDialysis role
MethanolStrong indication in severe poisoning, acidosis, visual symptoms, high level, or renal failure
UremiaNot an ingested toxin, but retained uremic solutes cause toxicity
Diabetic ketoacidosisDialysis is not routine, but may be needed for refractory hyperkalemia, overload, or renal failure
Propylene glycolConsider in severe toxicity, acidosis, renal failure, or high concentration
Isoniazid / ironDialysis has limited or selective roles, not routine first-line therapy
LithiumImportant indication in severe toxicity, neurologic manifestations, renal impairment, or prolonged elimination
Ethylene glycolStrong indication in severe poisoning, high anion-gap acidosis, renal failure, or high level
SalicylatesImportant in severe poisoning, CNS symptoms, pulmonary edema, severe acidemia, renal failure, or very high level
Metformin-associated lactic acidosisConsider when severe lactic acidosis, shock, renal failure, or clinical deterioration
Valproic acidConsider in severe poisoning with coma, cerebral edema, shock, severe acidosis, or high serum levels
TheophyllineConsider for severe poisoning with arrhythmia, seizures, or refractory instability
For AKI, standard teaching sources specifically include methanol, ethylene glycol, and salicylate poisoning among conditions that should be treated with hemodialysis. The Washington Manual of Medical Therapeutics, p. 484.
For poisonings, consult a toxicologist or poison center immediately because the indication depends on symptoms, acid-base status, renal function, and measured drug level, not the drug name alone.

O. Fluid overload

Indication

Dialysis or ultrafiltration is indicated when there is clinically important volume overload that cannot be controlled medically.

Typical situations

  • Acute pulmonary edema with hypoxemia
  • Pulmonary edema requiring high-flow oxygen, noninvasive ventilation, or intubation
  • Persistent edema with severe hypertension despite appropriate diuretics
  • Oliguric or anuric AKI with ongoing fluid accumulation
  • Severe heart failure with kidney failure and diuretic resistance
  • Inability to provide necessary nutrition, blood products, antibiotics, or other IV therapy because of fluid overload
  • Refractory ascites or generalized edema in selected kidney-failure scenarios

Key idea

“Edema present” is not itself an automatic dialysis indication. The indication is uncontrolled, clinically harmful congestion, especially pulmonary edema or inability to maintain oxygenation and hemodynamic stability.
Volume overload is often the most common reason for acute RRT in ICU AKI. The dialysis modality depends on hemodynamic stability:
Patient conditionUsually preferred approach
Hemodynamically stableIntermittent hemodialysis or isolated ultrafiltration
Shock, vasopressor requirement, severe instabilityCRRT or prolonged intermittent kidney replacement therapy
Severe cerebral edema or acute liver failureUsually CRRT because fluid and solute shifts are gentler

U. Uremic complications

Uremia is not defined by a single urea or BUN value. It is a clinical syndrome from retained solutes in severe kidney failure.

Major urgent uremic indications

1. Uremic pericarditis

Features:
  • Pleuritic chest pain
  • Pericardial friction rub
  • Pericardial effusion
  • ECG findings may occur, but may be absent
  • Risk of tamponade
Uremic pericarditis is a strong indication for urgent dialysis.

2. Uremic encephalopathy

Features:
  • Confusion
  • Reduced attention
  • Asterixis
  • Myoclonus
  • Delirium
  • Seizures
  • Coma
This requires urgent dialysis after other causes of altered mental state are assessed.

3. Uremic bleeding

Uremia causes qualitative platelet dysfunction. Consider dialysis when there is clinically significant bleeding or an urgent invasive procedure in severe uremia, together with standard measures such as desmopressin where appropriate.

4. Severe uremic gastrointestinal symptoms

  • Persistent nausea
  • Vomiting
  • Anorexia
  • Inability to maintain nutrition
  • Weight loss

5. Other uremic manifestations

  • Severe, intractable pruritus
  • Serositis
  • Restless legs and severe sleep disturbance, after other treatment options
  • Severe fatigue with clear uremic symptom burden
  • Progressive malnutrition or protein-energy wasting

2. Dialysis initiation in chronic kidney disease / kidney failure

For progressive CKD, dialysis should not be commenced solely because eGFR crosses a fixed number.
KDIGO recommends initiation based on a composite assessment of:
  • Symptoms and signs
  • Quality of life
  • Patient preference and goals of care
  • GFR trajectory
  • Laboratory abnormalities
  • Ability to control fluid and BP
  • Nutritional state
According to the KDIGO 2024 CKD guideline, dialysis is often, but not always, started when GFR is roughly 5-10 mL/min/1.73 m².

Chronic dialysis indications

DomainIndications
Uremic symptomsPericarditis, encephalopathy, persistent anorexia, nausea/vomiting, pruritus, serositis
Electrolytes / acid-baseMedically resistant hyperkalemia, acidosis, or other serious abnormalities
Volume and BPInability to control volume status or hypertension despite appropriate medical management
NutritionProgressive weight loss, protein-energy wasting, or declining nutritional status despite intervention
Cognition / functionCognitive impairment or severe functional decline attributable to kidney failure
Patient-centered factorsSymptom burden, treatment goals, preference, feasibility of conservative care or transplantation

Preparation before dialysis is needed

Preparing for dialysis is not the same as starting dialysis.
KDIGO suggests planning for dialysis access and/or preemptive transplantation in adults when:
  • eGFR is <15-20 mL/min/1.73 m², or
  • the estimated 2-year kidney failure risk is >40%.
Preparation includes:
  • Education about hemodialysis, peritoneal dialysis, home dialysis, transplant, and conservative kidney management
  • AV fistula or graft planning when HD is likely
  • Peritoneal dialysis catheter planning when PD is selected
  • Living donor evaluation
  • Vaccination and infection prevention
  • Anemia, CKD-mineral bone disorder, nutrition, BP, and volume optimization

3. AKI: when not to start dialysis immediately

In AKI, do not start dialysis automatically for:
  • Oliguria alone
  • Creatinine rise alone
  • BUN rise alone
  • AKI stage alone
  • Sepsis alone
  • Contrast exposure alone
  • Mild hyperkalemia that responds to treatment
  • Mild metabolic acidosis responsive to treatment
  • Edema that responds to diuretics and does not cause organ dysfunction
Early initiation before definitive indications has not consistently shown better outcomes. In sepsis-associated AKI, standard indications such as progressive acidemia, hyperkalemia, uremia, or volume overload guide initiation. Harrison’s Principles of Internal Medicine, 22nd ed., p. 2440.
A recent systematic review also indicates that the question of “early versus delayed” RRT remains dependent on patient selection and clinical context rather than a universal laboratory trigger. PMID: 41894268.

4. Choosing the dialysis modality

The indication may be the same, but the modality changes according to stability and clinical goals.
Clinical situationPreferred modality
Severe hyperkalemia in stable patientIntermittent hemodialysis for rapid potassium removal
Severe pulmonary edema in stable patientIntermittent HD with UF or isolated UF
Septic shock / vasopressor-dependent patientCRRT or prolonged intermittent therapy
Acute brain injury / raised intracranial pressureCRRT to avoid rapid osmotic shifts
Acute liver failure with hyperammonemia / cerebral edema riskCRRT often preferred
Chronic stable kidney failureIn-center HD, home HD, peritoneal dialysis, or transplantation depending on patient factors
Hemodynamic instability during standard HDConsider slower therapies, cooler dialysate, modified UF, or CRRT as clinically appropriate

5. Practical nephrology checklist before prescribing dialysis

Before starting dialysis, assess:

A. Is there an absolute or urgent indication?

Refractory K+?
Severe acidosis?
Pulmonary edema / uncontrolled volume?
Uremic pericarditis or encephalopathy?
Dialyzable toxin?

B. Has correct medical therapy been attempted?

  • Hyperkalemia protocol
  • Diuretics if appropriate and patient is likely responsive
  • Bicarbonate in suitable acidemia
  • Treatment of shock, sepsis, obstruction, and nephrotoxins
  • Fluid restriction and sodium restriction
  • Control of ongoing tissue breakdown, bleeding, or toxin absorption

C. What is the hemodynamic state?

  • Stable: intermittent HD possible
  • Unstable / vasopressors: CRRT or slow hybrid therapy may be safer

D. What is the real treatment objective?

  • Rapid potassium removal?
  • Net fluid removal?
  • Correction of acidosis?
  • Uremic toxin clearance?
  • Poison removal?
  • Control of severe azotemia while awaiting recovery?

E. Is conservative management appropriate?

For some frail patients with advanced CKD, severe comorbidity, or a care goal focused on comfort, comprehensive conservative kidney management may be preferable to dialysis. This requires shared decision-making, not automatic dialysis initiation.

One-page summary

DIALYZE URGENTLY WHEN:

A  = Acidosis: severe and refractory
E  = Electrolyte: refractory hyperkalemia, especially ECG changes
I  = Intoxication: dialyzable poison causing severe toxicity
O  = Overload: refractory pulmonary edema / dangerous volume excess
U  = Uremia: pericarditis, encephalopathy, bleeding, seizures,
              intractable GI symptoms, severe symptomatic uremia
DO NOT USE A SINGLE NUMBER ALONE:

Not creatinine alone
Not BUN alone
Not eGFR alone
Not oliguria alone
Not one potassium value without context

Use symptoms + exam + ECG + fluid status + trends + response to therapy.
This is a shared conversation. Sign in to Orris to start your own chat.